1. Home
  2. NEPH vs ALGS Comparison

NEPH vs ALGS Comparison

Compare NEPH & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$3.49

Market Cap

31.0M

Sector

Health Care

ML Signal

HOLD

Logo Aligos Therapeutics Inc.

ALGS

Aligos Therapeutics Inc.

HOLD

Current Price

$6.42

Market Cap

37.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEPH
ALGS
Founded
1997
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.0M
37.1M
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
NEPH
ALGS
Price
$3.49
$6.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$6.00
$39.33
AVG Volume (30 Days)
20.5K
209.4K
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
1000.00
88.30
EPS
0.01
N/A
Revenue
$18,789,000.00
$2,186,000.00
Revenue This Year
$11.24
$32.20
Revenue Next Year
$11.58
$4.71
P/E Ratio
$28.41
N/A
Revenue Growth
32.67
N/A
52 Week Low
$2.05
$5.12
52 Week High
$6.42
$13.69

Technical Indicators

Market Signals
Indicator
NEPH
ALGS
Relative Strength Index (RSI) 60.66 46.06
Support Level $2.77 $6.25
Resistance Level $4.92 $8.30
Average True Range (ATR) 0.29 0.49
MACD 0.05 -0.01
Stochastic Oscillator 63.84 55.24

Price Performance

Historical Comparison
NEPH
ALGS

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About ALGS Aligos Therapeutics Inc.

Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.

Share on Social Networks: